Type 1 Diabetes Drugs Market Report

China Type 1 Diabetes Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：201
  • REPORT CODE：GMM1776868
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Type 1 Diabetes Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merrion Pharmaceutical

    • GlaxoSmithKline

    • Osiris Therapeutics

    • Gan & Lee Pharmaceuticals

    • Boehringer Ingelheim

    • Tolerio

    • Astellas Pharma

    • Pfizer

    • Perle Biosciences

    • Eli Lily

    • AstraZeneca

    • Novo Nordisk

    • Generex Biotechnology

    • Sanofi

    • Adocia

    By Type:

    • Other

    • Long-Acting Insulin

    • Intermediate-Acting Insulin

    • Fast-Acting Insulin

    By Application:

    • Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Type 1 Diabetes Drugs Market Overview 2018-2029

    • 1.1 China Type 1 Diabetes Drugs Industry Development Overview

    • 1.2 China Type 1 Diabetes Drugs Industry Development History

    • 1.3 China Type 1 Diabetes Drugs Industry Market Size (2018-2029)

    • 1.4 China Type 1 Diabetes Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.2 China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Long-Acting Insulin (2018-2029)

      • 1.4.3 China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Intermediate-Acting Insulin (2018-2029)

      • 1.4.4 China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Fast-Acting Insulin (2018-2029)

    • 1.5 China Type 1 Diabetes Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Type 1 Diabetes Drugs Market Analysis by Region

      • 1.6.1 North China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Type 1 Diabetes Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Type 1 Diabetes Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Type 1 Diabetes Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Type 1 Diabetes Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Type 1 Diabetes Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Type 1 Diabetes Drugs Industry Development

    Chapter 3 Type 1 Diabetes DrugsIndustry Chain Analysis

    • 3.1 Type 1 Diabetes Drugs Industry Chain

    • 3.2 Type 1 Diabetes Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Type 1 Diabetes Drugs Market

    • 3.3 Type 1 Diabetes Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Type 1 Diabetes Drugs Market

    Chapter 4 China Type 1 Diabetes Drugs Market, by Type

    • 4.1 China Type 1 Diabetes Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Type 1 Diabetes Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Type 1 Diabetes Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Type 1 Diabetes Drugs Production Volume and Growth Rate of Other

      • 4.5.2 China Type 1 Diabetes Drugs Production Volume and Growth Rate of Long-Acting Insulin

      • 4.5.3 China Type 1 Diabetes Drugs Production Volume and Growth Rate of Intermediate-Acting Insulin

      • 4.5.4 China Type 1 Diabetes Drugs Production Volume and Growth Rate of Fast-Acting Insulin

    Chapter 5 China Type 1 Diabetes Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Type 1 Diabetes Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Type 1 Diabetes Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Type 1 Diabetes Drugs Market Size and Growth Rate of Clinics

      • 5.5.2 China Type 1 Diabetes Drugs Market Size and Growth Rate of Hospitals

    Chapter 6 China Type 1 Diabetes Drugs Market, by Region

    • 6.1 China Type 1 Diabetes Drugs Production Volume and Production Value, by Region

    • 6.2 China Type 1 Diabetes Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Type 1 Diabetes Drugs Market Analysis

    • 7.1 North China Type 1 Diabetes Drugs Market, by Type

    • 7.2 North China Type 1 Diabetes Drugs Market, by Application

    Chapter 8 Central China Type 1 Diabetes Drugs Market Analysis

    • 8.1 Central China Type 1 Diabetes Drugs Market, by Type

    • 8.2 Central China Type 1 Diabetes Drugs Market, by Application

    Chapter 9 South China Type 1 Diabetes Drugs Market Analysis

    • 9.1 South China Type 1 Diabetes Drugs Market, by Type

    • 9.2 South China Type 1 Diabetes Drugs Market, by Application

    Chapter 10 East China Type 1 Diabetes Drugs Market Analysis

    • 10.1 East China Type 1 Diabetes Drugs Market, by Type

    • 10.2 East China Type 1 Diabetes Drugs Market, by Application

    Chapter 11 Northeast China Type 1 Diabetes Drugs Market Analysis

    • 11.1 Northeast China Type 1 Diabetes Drugs Market, by Type

    • 11.2 Northeast China Type 1 Diabetes Drugs Market, by Application

    Chapter 12 Southwest China Type 1 Diabetes Drugs Market Analysis

    • 12.1 Southwest China Type 1 Diabetes Drugs Market, by Type

    • 12.2 Southwest China Type 1 Diabetes Drugs Market, by Application

    Chapter 13 Northwest China Type 1 Diabetes Drugs Market Analysis

    • 13.1 Northwest China Type 1 Diabetes Drugs Market, by Type

    • 13.2 Northwest China Type 1 Diabetes Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merrion Pharmaceutical

        • 14.1.1 Merrion Pharmaceutical Company Profile

        • 14.1.2 Merrion Pharmaceutical Type 1 Diabetes Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GlaxoSmithKline

        • 14.2.1 GlaxoSmithKline Company Profile

        • 14.2.2 GlaxoSmithKline Type 1 Diabetes Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Osiris Therapeutics

        • 14.3.1 Osiris Therapeutics Company Profile

        • 14.3.2 Osiris Therapeutics Type 1 Diabetes Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Gan & Lee Pharmaceuticals

        • 14.4.1 Gan & Lee Pharmaceuticals Company Profile

        • 14.4.2 Gan & Lee Pharmaceuticals Type 1 Diabetes Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Boehringer Ingelheim

        • 14.5.1 Boehringer Ingelheim Company Profile

        • 14.5.2 Boehringer Ingelheim Type 1 Diabetes Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Tolerio

        • 14.6.1 Tolerio Company Profile

        • 14.6.2 Tolerio Type 1 Diabetes Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Astellas Pharma

        • 14.7.1 Astellas Pharma Company Profile

        • 14.7.2 Astellas Pharma Type 1 Diabetes Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Pfizer

        • 14.8.1 Pfizer Company Profile

        • 14.8.2 Pfizer Type 1 Diabetes Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Perle Biosciences

        • 14.9.1 Perle Biosciences Company Profile

        • 14.9.2 Perle Biosciences Type 1 Diabetes Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Eli Lily

        • 14.10.1 Eli Lily Company Profile

        • 14.10.2 Eli Lily Type 1 Diabetes Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AstraZeneca

        • 14.11.1 AstraZeneca Company Profile

        • 14.11.2 AstraZeneca Type 1 Diabetes Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Novo Nordisk

        • 14.12.1 Novo Nordisk Company Profile

        • 14.12.2 Novo Nordisk Type 1 Diabetes Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Generex Biotechnology

        • 14.13.1 Generex Biotechnology Company Profile

        • 14.13.2 Generex Biotechnology Type 1 Diabetes Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Sanofi

        • 14.14.1 Sanofi Company Profile

        • 14.14.2 Sanofi Type 1 Diabetes Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Adocia

        • 14.15.1 Adocia Company Profile

        • 14.15.2 Adocia Type 1 Diabetes Drugs Market Performance

        • 14.15.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Type 1 Diabetes Drugs Industry Research Conclusions

    • 15.2 Type 1 Diabetes Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Type 1 Diabetes Drugs Industry Market Size (2018-2029)

    • Figure China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Long-Acting Insulin (2018-2029)

    • Figure China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Intermediate-Acting Insulin (2018-2029)

    • Figure China Type 1 Diabetes Drugs Production Volume, Production Value and Growth Rate of Fast-Acting Insulin (2018-2029)

    • Figure China Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Type 1 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Type 1 Diabetes Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Type 1 Diabetes Drugs Market Share by Type in 2018

    • Figure China Type 1 Diabetes Drugs Market Share by Type in 2023

    • Figure China Type 1 Diabetes Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Volume and Growth Rate of Long-Acting Insulin (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Volume and Growth Rate of Intermediate-Acting Insulin (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Volume and Growth Rate of Fast-Acting Insulin (2018-2023)

    • Figure China Type 1 Diabetes Drugs Market Share by Application in 2018

    • Figure China Type 1 Diabetes Drugs Market Share by Application in 2023

    • Figure China Type 1 Diabetes Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Type 1 Diabetes Drugs Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Type 1 Diabetes Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Type 1 Diabetes Drugs Production Volume by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Production Volume Share by Region (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Volume Share by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Production Value by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Production Value Share by Region (2018-2023)

    • Figure China Type 1 Diabetes Drugs Production Value Share by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Sales Volume by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Type 1 Diabetes Drugs Sales Volume Share by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Sales Value by Region (2018-2023)

    • Table China Type 1 Diabetes Drugs Sales Value Share by Region (2018-2023)

    • Figure China Type 1 Diabetes Drugs Sales Value Share by Region (2018-2023)

    • Table North China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table North China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table North China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table North China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Central China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Central China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table South China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table South China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table South China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table East China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table East China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table East China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Type 1 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Type 1 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Type 1 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Type 1 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Merrion Pharmaceutical Company Profile

    • Table Merrion Pharmaceutical Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Osiris Therapeutics Company Profile

    • Table Osiris Therapeutics Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Gan & Lee Pharmaceuticals Company Profile

    • Table Gan & Lee Pharmaceuticals Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Tolerio Company Profile

    • Table Tolerio Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Perle Biosciences Company Profile

    • Table Perle Biosciences Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lily Company Profile

    • Table Eli Lily Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Generex Biotechnology Company Profile

    • Table Generex Biotechnology Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Adocia Company Profile

    • Table Adocia Type 1 Diabetes Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US